hydrochlorothiazide
- Product NDC
- 70518-1676
- 11-digit product format
- 705181676
- Labeler code
- 70518
- Product ID
- 70518-1676_e5cedec4-98fa-7aa2-e053-2995a90a5ae0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- hydrochlorothiazide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA090510
- Marketing category
- ANDA
- Marketing start
- 2018-11-16
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70518-1676 | D | Discontinued by firm | 2026-07-31 | ||
| excluded package | package | 70518-1676 | 70518-1676-0 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 70518-1676 | 70518-1676-1 | D | Discontinued by firm | 2026-07-31 | |
| excluded package | package | 70518-1676 | 70518-1676-2 | D | Discontinued by firm | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090510-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 12.5MG | CAPSULE / ORAL | AB | 2010-01-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090510-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090510-001 | HYDROCHLOROTHIAZIDE | 12.5MG | CAPSULE / ORAL | AB | 2010-01-19 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090510-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | e3afa83d-c79c-848a-e053-2a95a90ac922 | 2026-01-01 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | QPharma Inc | 578f74ea-53d1-4c44-b872-66033292abe0 | 2025-12-05 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 13ed002f-c5bb-401c-891a-70b70cbd8fb6 | 2025-06-18 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Quality Care Products LLC | a2de8e26-ef5a-41c7-888b-990629b11145 | 2024-12-19 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 6a11a458-dc69-40ba-a58a-649733e0e8ab | 2024-05-29 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 39d4dbd3-8f24-4898-a240-e94e06fa229a | 2024-04-11 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | cb7712f3-9a0b-442d-859d-8be5e6e2529a | 2024-03-29 | Warnings, Adverse reactions | 090510 ANDA090510 |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 98edae8a-99dc-4f26-a956-3ad58bf38a26 | 2022-06-01 | Warnings, Adverse reactions | 090510 ANDA090510 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-1676-1 | 70518167601 | 60 CAPSULE in 1 BLISTER PACK (70518-1676-1) | 60 capsule | 2022-05-31 | 0000-00-00 | No | No | Current |
| 70518-1676-2 | 70518167602 | 100 POUCH in 1 BOX (70518-1676-2) > 1 CAPSULE in 1 POUCH (70518-1676-3) | 100 pouch | 2022-06-15 | 0000-00-00 | No | No | Current |